Patient advocate death 'devastating'

Tributes are pouring in from across industry following the death of Russell Conley who stepped down as the CEO of the GI Cancer Institute in September after 22 years with the organisation - sadly succumbing to the disease he spent his entire career fighting.

To see the whole article please log in.

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

Retype password

Not a member? Sign up here